Screener
Disc Medicine IRON Operating Income
Discontinued — last reported Q1 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development | $45,904 | $27,763 |
| Selling, general and administrative | 23,620 | 12,183 |
| Total operating expenses | 69,524 | 39,946 |
| Loss from operations | (69,524) | (39,946) |
| Other income (expense), net: | ||
| Interest income | 6,893 | 6,880 |
| Interest expense | (844) | (897) |
| Other income (expense) | 22 | (3) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's operating income?
- Disc Medicine (IRON) reported operating income of -$69.52M in Q1 2026.
- How has Disc Medicine's operating income changed year-over-year?
- Disc Medicine's operating income decreased by 74.0% year-over-year, from -$39.95M to -$69.52M.
- What is the long-term trend for Disc Medicine's operating income?
- Over 3 years (2022 to 2025), Disc Medicine's operating income has grown at a 70.7% compound annual growth rate (CAGR), from -$47.48M to -$236.02M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Disc Medicine's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude